Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05161000 · ClinicalTrials.gov registry record · NA
Oral Nutritional Supplementation in Children at Risk of Undernutrition
A NA study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 279
- Enrollment target
NCT05161000: Completed NA study, sponsored by Abbott Nutrition.
NCT05161000 is a NA study that has completed, run by Abbott Nutrition. The registered enrollment target is 279 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05161000, a NA study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 279 participants
- Enrollment target
Study Summary
The objective of this randomized, controlled trial is to evaluate the effects of consuming a pediatric oral nutritional supplement (ONS) plus dietary counseling for 120 days on anthropometric growth, strength, and nutritional status, compared with dietary counseling alone in undernourished children in the United States.
Primary Outcome
Change in weight-for-age z-score
Interventions
- OTHER Oral Nutritional Supplement
- OTHER Dietary counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 279 participants |
| Start Date | 2022-04-18 |
| Est. Completion | 2024-06-11 |
| Phase | NA |
What the finished NCT05161000 record still lists
NCT05161000 is an interventional study that assigns participants to a tested intervention. The registered 279 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 2 interventions - of which Oral Nutritional Supplement is the first listed.
NCT05161000 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05161000 about?
NCT05161000 is a clinical study titled "Oral Nutritional Supplementation in Children at Risk of Undernutrition". The objective of this randomized, controlled trial is to evaluate the effects of consuming a pediatric oral nutritional supplement (ONS) plus dietary counseling for 120 days on anthropometric growth, strength, and nutritional status, compared with dietary counseling alone in undernourished children ...
What is the current status of trial NCT05161000?
This trial is currently completed. It is a NA study. The enrollment target is 279 participants. The study started on 2022-04-18. Estimated completion is 2024-06-11.
What interventions are being tested in trial NCT05161000?
The interventions under investigation include: Oral Nutritional Supplement (OTHER), Dietary counseling (OTHER).
Who is sponsoring clinical trial NCT05161000?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05161000's enrollment target sits among peer trials
279 381st of 2000 higher than 1,619 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04783857 · 279 participants · Phase 4
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
- NCT05407324 · 279 participants · Phase 2
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
- NCT06299748 · 279 participants
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
- NCT06582784 · 279 participants · NA
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI